These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6400301)

  • 21. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
    Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
    Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
    [No Abstract]   [Full Text] [Related]  

  • 23. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
    Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
    Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful field trials with oral killed Shigella sonnei vaccine.
    Grahneis H
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
    [No Abstract]   [Full Text] [Related]  

  • 25. [Field trials with an oral cell-free vaccine made from Shigella flexneri].
    Sergeev VV; Kreĭnin LS; Elkina SI; Kaverina KG; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Oct; (10):54-9. PubMed ID: 2692352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF
    Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
    [No Abstract]   [Full Text] [Related]  

  • 27. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a new phage preparation in prophylaxis and treatment of shigellosis.
    Mulczyk M; Slopek S
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):115-9. PubMed ID: 4613130
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
    Joó I
    Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interrelation of virulent and avirulent (vaccinal) strains of Shigella flexneri 2A in long-term bacterial carriage in gnotobiotic rats].
    Belaia IuA; Chakhava OV; Bystrova SM; Shustrova NM; Popova LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):82-9. PubMed ID: 6375221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral shigella vaccines.
    Hale TL; Formal SB
    Curr Top Microbiol Immunol; 1989; 146():205-11. PubMed ID: 2659269
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
    [No Abstract]   [Full Text] [Related]  

  • 33. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
    Levine MM; Gangarosa EJ; Werner M; Morris GK
    J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preparation of a live Shigella vaccine using T32 strain (Roumania) in a form of popsicle and observation of its prophylactic efficacy].
    Zhao B
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):230-2. PubMed ID: 6640637
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.
    Mel DM; Arsić BL; Nikolić BD; Radovanić ML
    Bull World Health Organ; 1968; 39(3):375-80. PubMed ID: 5303905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity of Shigella in healthy carriers: a study in Vientiane, Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Insisiengmay S; Ichinose Y; Higa N; Song T; Iwanaga M
    Jpn J Infect Dis; 2005 Aug; 58(4):232-4. PubMed ID: 16116257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economical evaluation of the dysentery vaccination in B Municipality.
    Pănoiu L; Ion-Nedelcu N
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):337-40. PubMed ID: 6400308
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.